n-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium and Atherosclerotic Parkinsonism

n-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium has been researched along with Atherosclerotic Parkinsonism in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anemo, K; Igarashi, K; Iwahashi, K; Nakamura, K; Yoshihara, E	1

Other Studies

1 other study(ies) available for n-(4'-fluorobutyrophenone)-4-(4-chlorophenyl)pyridinium and Atherosclerotic Parkinsonism

Article	Year
Analysis of the metabolism of haloperidol (HP) and its neurotoxic pyridinium metabolite (HPP+) in patients with drug-induced parkinsonism. Clinica chimica acta; international journal of clinical chemistry, 2000, Volume: 298, Issue:1-2 Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Haloperidol; Humans; Middle Aged; Mixed Function Oxygenases; Parkinson Disease, Secondary; Pyridinium Compounds	2000

Article

Year

Analysis of the metabolism of haloperidol (HP) and its neurotoxic pyridinium metabolite (HPP+) in patients with drug-induced parkinsonism.

Clinica chimica acta; international journal of clinical chemistry, 2000, Volume: 298, Issue:1-2

Topics: Adult; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Haloperidol; Humans; Middle Aged; Mixed Function Oxygenases; Parkinson Disease, Secondary; Pyridinium Compounds

2000